Martin Joseph Joyce is Director at Aldeyra Therapeutics, Inc. (ALDX). They have made 6 open-market trades across 2 companies since 2006, most recently 2022-06-23.
CIK 0001300858
6 open-market purchases totalling $150K since 2006, never a sale. Across 5 scored buys the stock is up 1.5% at ninety days, and 1.1 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 60% | 60% |
| Avg Move | +1.4% | +4.7% | +1.5% |
| Alpha | +3.8% | +4.4% | +1.1% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALDX | BUY | 2022-06-23 | 2022-06-27 | $3.48 | $15K | +13.7% | +27.8% | +34.7% |
| ALDX | BUY | 2019-09-12 | 2019-09-16 | $5.86 | $10K | -6.6% | -4.8% | -15.9% |
| ALDX | BUY | 2017-02-17 | 2017-02-21 | $4.50 | $20K | +1.0% | -2.1% | -13.9% |
| ALDX | BUY | 2014-08-07 | 2014-08-07 | $3.95 | $4K | -0.6% | +1.4% | +1.4% |
| ALDX | BUY | 2014-05-07 | 2014-05-08 | $8.00 | $100K | -0.6% | +1.4% | +1.4% |
| BSMD | BUY | 2006-06-01 | 2006-06-05 | $0.01 | $1K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.